chrisvoncsefalvay/vaers-outcomes huggingface dataset:
anaphylactic reaction; This is a spontaneous report from a contactable pharmacist. This Pharmacist reported for two patients. This is the second of two reports regards to a female patient. A 29-year-old female patient received first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE) intramuscular, administered in Deltoid Left on 02Jun2021 (Batch/Lot Number: EW0178; Expiration Date: Aug2021) at the age of 29-year-old, as 1st dose, single for covid-19 immunisation. The patient medical history was not reported. The patient's concomitant medications was reported as taking other medication (unspecified). The patient experienced anaphylactic reaction on 02Jun2021. They took her to the hospital. It was reported the vaccine shot was between 11:30 and 12:00 in the morning. The patient experienced anaphylactic reaction literally like may be within 5 minutes after taking the shot. So its again 11:30 or 12:00. The outcome of event was unknown.   Information on Lot/Batch number is available; Further information has been requested.; Sender's Comments: Based on the plausible temporal relationship and known drug safety profile, a possible causal relationship between the event Anaphylactic reaction and suspect drug BNT162B2 cannot be excluded.,Linked Report(s) : US-PFIZER INC-2021641495 same reporter, product, different patient and similar events.
Pt. with history of fever on this day of 100.0 Also cough, rhinorrhea for 2-3 days. Pt. was brought to ER by parents because she had episode of what appears to be febrile seizure at 1930 . Pt's eyes rolled backwards, she was clenching teeth, her arms were shivering, this lasted 30 to 60 seconds.
Administered the pedi dose and the student is 12yo. The student did not exhibit any adverse reaction to the vaccine. Parent notified.
2hr p/vax pt became pale & dusky & limp;pt taken to ER adm for short stay observation;pt improved p/adm;
This spontaneous case was reported by a consumer and describes the occurrence of HERPES ZOSTER (may be shingles), SWELLING FACE (right sided facial swelling), RASH PRURITIC (rash is itching and burning), SKIN BURNING SENSATION (rash is burning) and RASH (rash on the right side of their neck) in a 42-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 078J21A, 012M20A and 026L20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below. The patient's past medical history included COVID-19 in September 2021. Concurrent medical conditions included Latex allergy. Concomitant products included CALCIUM, COLECALCIFEROL (CALCIUM & VITAMIN D [CALCIUM; COLECALCIFEROL]) and SERTRALINE HYDROCHLORIDE (ZOLOFT) for an unknown indication. On 09-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 09-Feb-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 08-Jan-2022, received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 09-Jan-2022, the patient experienced VACCINATION SITE PAIN (soreness of the site). 09-Jan-2022, the patient experienced FATIGUE (fatigue). In January 2022, the patient experienced HERPES ZOSTER (may be shingles), SWELLING FACE (right sided facial swelling), RASH PRURITIC (rash is itching and burning), SKIN BURNING SENSATION (rash is burning), RASH (rash got to their back, and all over their body, including knees, elbows and hands) and MYALGIA (muscle aches in both their upper arms). On 18-Jan-2022, the patient experienced RASH (rash on the right side of their neck). The patient was treated with PREDNISONE at a dose of high dose prednisone, 50; CETIRIZINE HYDROCHLORIDE (ZYRTEC [CETIRIZINE HYDROCHLORIDE]) for Itchy rash, at a dose of 10 milligram and FAMOTIDINE (PEPCID AC) at a dose of 20mg twice a day. At the time of the report, HERPES ZOSTER (may be shingles), SWELLING FACE (right sided facial swelling), RASH PRURITIC (rash is itching and burning), SKIN BURNING SENSATION (rash is burning), VACCINATION SITE PAIN (soreness of the site), FATIGUE (fatigue) and MYALGIA (muscle aches in both their upper arms) outcome was unknown and RASH (rash on the right side of their neck) and RASH (rash got to their back, and all over their body, including knees, elbows and hands) had not resolved. For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments. This case was linked to MOD-2022-462296 (Patient Link).
Long term irregular heart beat, PVCs, Shortness of breath/difficulty getting a full breath, fatigue, chest pain Slowly self corrected over 9+ weeks
Information has been received from a healthcare worker referring to a 8 months old patient of unknown gender. Concurrent conditions, medical history of the patient were not reported. On 23-MAR-2015 the patient was vaccinated with a dose of VAQTA (lot#, expiry date, dose, route unspecified) when the patient was 8 months old (Inappropriate scheudle of vacine administered). Concmitant therapies were not reported. No adverse effects reported. No product quality complaint (PQC) involved. Additional information has been requested.
Normal labor and delivery on 10/31/2021. Hospital admission within 6 weeks of receiving the COVID vaccine.
Intermittent low spO2 ranging from 90-93. Normally lasts ~15min, then back to normal. No ill effects, my watch measures spO2 and let?s me know when low.
Information has been received from a healthcare worker referring to a patient of unknown age and gender. Information about patient's concomitant medications, concurrent conditions and medical history as not reported. On 29-JAN-2016 the patient was vaccinated with a dose of (Merck) VARIVAX (dose and route not reported, lot number L032394 with expiration date 26-AUG-2017) that had been improperly stored (temperature ranges: 5.5F to 11.8F and time frame: 11 hours and 30 minutes). It was reported that there was a previous temperature excursion: 11.5 F for 14 hours. No adverse effects were reported. This is one of three reports received from the same reporter (other linked case # 1603USA010044 and 1603USA010237). Additional information is not expected because there was no consent to contact the physician for follow up.
face swelling up; rash all over her body; This spontaneous case was reported by a consumer and describes the occurrence of SWELLING FACE (face swelling up) and RASH (rash all over her body) in a 74-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 032M20A and 007M20A) for COVID-19 vaccination.     Concurrent medical conditions included Lupus syndrome and Autoimmune disorder.   On 13-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 13-Mar-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 14-Mar-2021, the patient experienced SWELLING FACE (face swelling up) and RASH (rash all over her body). At the time of the report, SWELLING FACE (face swelling up) and RASH (rash all over her body) was resolving.            The action taken with mRNA-1273(Moderna COVID-19 Vaccine) was not applicable  Treatment details included antihistamines (names not specified).  No concomitant medications were reported.   Most recent FOLLOW-UP information incorporated above includes: On 20-Jun-2021: Other relevant history in patient tab added, outcome of event changed from unknown to recovering.
patients injection arm started to swell and became very painful to touch for approx. 2 weeks.
FEVER; HEADACHE; This spontaneous report received from a patient via a company representative concerned a male of unspecified age. The patient's weight, height, and medical history were not reported. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: Unk) dose, start therapy date were not reported for prophylactic vaccination. The batch number was not reported. The Company is unable to perform follow-up to request batch/lot numbers. No concomitant medications were reported. On MAR-2021, the subject experienced headache. On an unspecified date, the subject experienced fever. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The outcome of the fever and headache was not reported. This report was non-serious. This case, from the same reporter is linked to 20210355949.
Patient received vaccine on 03/23/2016 at CBOC. He called CBOC reporting symptoms and presented for nursing appointment on 3/25.  Rash, Urticaria, Pruritus and Diarrhea.
I started with a lot of pain in my left shoulder, it's hard for me to comb my hair, I have weakness in my shoulder and now after the vaccine my arm hurts. I feel a lot of headache, I have dizziness. I went to the doctor and he told me that it was possible Vertigo. He recommended an MRI I'm afraid to do it. When I go to bed and get up I get very dizzy. The Sciatic on  my left leg hurts a lot, buttocks and waist hurt. They made a chest x-ray because I am short of breath, the doctor told me that I have the beginnings of Bronchitis. They prescribed me only Ibuprofen and a depression pill
10 pm same day sore arm 4/9 fatigue, muscle aches 4/10 fatigue, muscle aches, pain when inhaling
This case was reported by a consumer via call center representative and described the occurrence of diarrhea in a female patient who received SHINGRIX for prophylaxis. On 8th June 2018, the patient received the 1st dose of SHINGRIX. In June 2018, less than a week after receiving SHINGRIX, the patient experienced diarrhea, chills, injection site pain and injection site erythema. On an unknown date, the outcome of the diarrhea, chills, injection site pain and injection site erythema were not recovered/not resolved. It was unknown if the reporter considered the diarrhea, chills, injection site pain and injection site erythema to be related to SHINGRIX. Additional details were provided as follows: The age at vaccination was not reported. At the date of reporting, the patient had some diarrhea and chills and the patient was asking is there anything to help that. The reporter was asking, how long the pain and redness at injection site would last.
I've suffered three Excruciating migraines since I've taken my 1st vaccine dose. I suffered loss of vision with aura, vomiting, worsened pain in head, and nausea. I usually suffer migraines in the spring, not any other time. So I know for sure the migraines are certainly caused by the vaccine.
Patient was hospitalized due to shortness of breath, productive cough, and fatigue in addition to an elevated troponin result. He was coincidentally tested for COVID-19 which was positive.
headaches; This spontaneous case was reported by a consumer and describes the occurrence of HEADACHE (headaches) in an 86-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No medical history was provided by the reporter.     On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced HEADACHE (headaches). At the time of the report, HEADACHE (headaches) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Concomitant product use was not provided by the reporter.  Treatment information was not provided.
This report refers to unknown number of patients of enrolled in a investigator initiated study. On unspecified dates, the patients received GARDASIL that were improperly stored. No adverse event reported. Couple of deviations from weekly temperatures: Period 30-JAN-2012 to 05-FEB-2012. Reported 30-JAN-2012 54 degrees F. Period 26-OCT-2011 to 30-OCT-2011. Reported 26-OCT-2011 47 degrees F. Period 22-AUG-2011 to 28-AUG-2011. Reported 22-AUG-2011 32 degrees F. Period 01-APR-2011. Reported 01-APR-2011 25 degrees F. No further information available.
small red spots, fussiness, low fever by 08/22/2011, numerous (>10) obvious chicken pox marks, 100.6 fever.
Shingles; all of the side effects listed on your site but severe; This case was reported by a nurse via call center representative and described the occurrence of shingles in a female patient who received Herpes zoster (Shingrix) for prophylaxis.   The patient's past medical history included shingles (has had shingles 7 times).   On an unknown date, the patient received the 1st dose of Shingrix. On an unknown date, unknown after receiving Shingrix, the patient experienced shingles and adverse drug reaction. On an unknown date, the outcome of the shingles and adverse drug reaction were recovered/resolved.   It was unknown if the reporter considered the shingles and adverse drug reaction to be related to Shingrix.  Additional details were provided as follows: The age at the vaccination was not reported. Nurse reported the symptoms that the patient had after the first dose was all of the side effects listed on GlaxoSmithKline site but severe. The reporter stated it was worse than the flu but only for about 48 hours. The reporter was trying to decide when to give her the second dose. Nurse ended the chat before additional information could be obtained.
4/13/04 sudden onset of Right ankle pain, woke with the pain. came to clinic for eval.  noted some slight swelling, some slight increased warmth,  Discomfort not relieved by ice, warmth or elevation.  Right lateral ankle was very painful to palpatation.  Given toradol and sent to ER.  ER physician  reporedly gave her anti inflammatory drugs and told her she had gout. Had started birth control pills within past 2 weeks. Nausea and vomiting and bad headache also.   episode lasted about 5 days
Hives spreading from right ear to the face and extremities and body. Pt with extreme itch such that she broke the skin with the digging into the skin. She was drooling but her throat was clear and airway patent without uvula swelling. There was no wheezing.
dizzy; This is a spontaneous report received from contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 45 year-old male patient received bnt162b2 (BNT162B2), administered in arm left, administration date 25Mar2021 17:45 (Batch/Lot number: unknown) at the age of 45 years as dose 1, single for covid-19 immunisation. The patient's relevant medical history was not reported. The patient took concomitant medications. The following information was reported: DIZZINESS (non-serious) with onset 30Mar2021 05:00, outcome "not recovered", described as "dizzy". Therapeutic measures were not taken as a result of dizziness.  Additional information: No other vaccine in four weeks. The patient received Vitamins within 2 weeks of vaccination. The patient reported that in the morning of 30Mar2021 at 5 AM when the patient tried to leave bed, he got dizzy. He has been like this all day when he looks up. Prior to vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient has not been tested for COVID-19. No Known allergies.  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
Day 5 post inoculation..dizzy with loss equilibrium for 2 1/2 days...again 2 weeks later same
Chills and body aches started taround noon on November 4. Chills lasted until around 2::00 am on November 5.  Nausea, headache, diarrhea body aches on November 5.  Headache still
Both arms were slightly sore at the site of the injections.  At 9:00 PM I began to be chilly, that turned to chills and shaking.  Took my temperature 99.8, it kept going up to 100.6 when I took one 650mg tablet of Acetaminophen.  I also had a slight headache and was very tired.   Fever broke around 12:30 AM.  When I got up on 9/11/19, my temperature was 99.4 and my headache was a little worse.  Took a second 650mg tablet of Acetaminophen.
RASHES WITH ITCHINESS SPREADING FROM ARMS TO BACK; This spontaneous report received from a patient concerned a male of unspecified age. The patient's weight, height, and medical history were not reported.  The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: Unknown) dose was not reported, administered on 10-APR-2021 for prophylactic vaccination. The batch number was not reported. The Company is unable to perform follow-up to request batch/lot numbers. No concomitant medications were reported.  On an unspecified date, the subject experienced rashes with itchiness spreading from arms to back. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The outcome of rashes with itchiness spreading from arms to back was not reported. This report was non-serious.
Persistent right sided headache, radiating over right eye to behind the ear; This is a spontaneous report from a contactable pharmacist. A 29-year-old male patient received BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Formulation: solution for injection, Batch/Lot Number: EN5318 ) via an unspecified route of administration, administered in left arm on 26Jan2021 (at the age of 29-year-old) as dose 2, single for COVID-19 immunization. The patient medical history was not reported. There were no concomitant medications. The patient had no known allergies. Historical vaccine included dose 1 of BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Formulation: solution for injection, Batch/Lot Number: EL0140) via an unspecified route of administration, administered in Arm Left on 04Jan2021 as dose 1, single for COVID-19 immunization. Patient received vaccine at hospital. The patient had not received any other vaccine in four weeks. The patient did not received any other medications in two weeks. The patient did not had covid prior vaccination and did not tested COVID post vaccination. On 01Feb2021, patient experienced persistent right sided headache, radiating over right eye to behind the ear. The patient did not received treatment for adverse event. The outcome of event was not recovered.  Follow-up (11MAY2021): Follow-up attempts completed. No further information expected.
pt recv vax & 22NOV96 pt had  abrupt onset of medial proximal thigh pain & refused to bear weight;afeb;urine cult-no growth;CBC: H/H 13/38;WBC 22,600, 39S, 8B, 92L, atypical 2+ ESR 11;LDH 1641;whole episode may have been toxic synovit
Total loss of smell and taste. I previously had 2 Covid19 Moderna vaccines and 3 Covid19 Moderna Bivalent vaccines, starting 02/12/2021.  And spaced over time with most recent on 09/14/2022.  After 2nd Covid19 Moderna vaccine, I started to loose my sense of smell and taste.  After each vaccine this became worse with greater loss of smell and taste.  The most recent vaccine on 09/14/2022 has left me with no smell or taste.
Fever to 103 7 days after MMR, lasting 3 days. Maculo-papular rash 8 days after MMR, persisting to 10 days.
Parent falsified the DOB of the child reporting to get the child vaccinated. Issue was discovered while entering the data. Parent was contacted and finally verified that the child is not yet 12 date of birth on record was correct. Parent wanted child vaccinated before going back to school.
Information has been received from a physician concerning a female patient in her 20's who was vaccinated with a first and second dose of Gardasil.  The physician reported that the patient had unusual soreness at the injection site after the first and second injection.  He also reported that the patient had unusual stiffness and weakness with local mechanical trouble after she was given the third dose of Gardasil.  The patient had not recovered as of this report day.  The physician reported that this is one of the three patients who experienced similar experiences.  Additional information has been requested. This is in follow-up to report (s) previously submitted on 09/17/2007.  Initial and follow up information has been received from a physician concerning a 27 year old female who was vaccinated with a first and second dose of GARDASIL.  The physician reported that the patient had unusual soreness at the injection site after the first and second injection.  He also reported that the patient had unusual stiffness nad weakness with local mechanical trouble after she was given the third dose of GARDASIL.  In follow up it was reported that on 27-JUL-2007, patient had shoulder tendenitis and myositis).  On 01-SEP-2007 patient recovered.  The reporter indicated that the patient's adverse event left shoulder tendenitis and myositis were disabling.  The physician reported that this is one of three patient who experienced similar experiences.  Additional information is not expected.
pt c/o h/a since 4AM; temp @ clinic 102.2 mom giving APAP but was using infant APAP pt weighs 155lbs; no evidence of redness or swelling @ site; PNP prescribed 500mg APAP every 4 hr PNP spoke to pt 14JUN95; pt better no fever, no h/a;
Head ache within 5 minutes of vaccine. Then along with headache, high blood pressure and rapid pulse. Temperature of 101.4 for several hours. Nausea has lasted for 4 days. Dizziness, weakness, lack of appetite and severe cold sores on upper lip. Soreness at vaccination site.
Systemic: Hyperglycemia -Medium, Additional Details: Pt has Type 1 diabetes and he experience hyperglycemia episode daily after the first dose. He is currently on an insulin pump and he noticed that his sugar level was higher than normal after the first dose. It started the day after the first dose and continued for 2 weeks. His sugar level has gone back to normal during his second visit.
I conceived my pregnancy less than 72 hours after getting my first covid shot, the pregnancy was ectopic and had to be medically terminated to prevent maternal death.
MODERNA COVID-19 VACCINE EUA 48 hours after receiving the vaccine, patient experienced extreme pain, sensitivity, and swelling in his left wrist and fingers. Approximately 24 hours later (72 hours post vaccination) patient reports that his right wrist and fingers were experiencing the same reaction. He is unable to make a fist, grip a water bottle, or open his medication bottles without assistance.
Severe headache, neck and lower back pain, vomiting, unable to eat, muscle cramps in legs, unable to move arms and shoulders, stomach pain, slight rash on chest and back, very weak, and unable to stay awake. Symptoms worsened through the day.  I contacted the school nurse at noon, then patient's DR at 1:30.  I was told by DR to take him to the ER.  An IV and pain meds were administered.  We were home by 5pm, he was feeling better and was able to eat a sandwich and went back to sleep for the night.  He continued to have pain especially in the neck and arms, ibuprofen was given. He is still at home with pain and weakness, but feeling better.
Headache  Fever 100.3 Muscle ache Fatigue Pain at injection site
This spontaneous report as received from a registered nurse refers to a patient of unknown age and gender. The patient's  concurrent conditions, medical history or concomitant medications were not reported. The nurse reported that on 26-FEB-2015 and on 29-APR-2015, the patient was vaccinated with improperly stored GARDASIL lot # J015378, expiry date 09-APR-2016 (dose and route of administration unspecified). No adverse symptoms were reported. This is one of several reports received from the same reporter. Additional information has been requested.
Swollen, firm, tender infraclavicular lymph node on side ipsilateral to injection site.  Swollen to the extent where it is visible without need for palpation.
Systemic: Dizziness / Lightheadness-Medium, Systemic: Tachycardia-Severe, Systemic: Tingling (specify: facial area, extemities)-Medium, Additional Details: Patient was having tachycardia after his dose. His heart rate went up to 142. We checked his blood pressure and heart rate 3 times. His vblood pressure was niormal but heart rate was consistenly elevated. WE called 911 and they took him to er